Histamine N-methyltransferase (HNMT) pharmacogenetics

Association of the C314T genetic polymorphism with allergic asthma

L. Yan, R. E. Galinsky, S. B. Liggett, Richard M Weinshilboum

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Asthma is an important public health problem that affects an estimated 150 million individuals worldwide. HNMT plays a dominant role in histamine biotransformation in bronchial epithelium. We have described a C314T polymorphism within the HNMT gene that results in a Thr105I1e change in encoded amino acid as well as decreased HNMT activity. We set out to determine whether this common genetic polymorphism might represent a risk factor for asthma. 63 asthmatic patients as well as 237 randomly selected blood donors were genotyped for the C314T polymorphism. The T314 variant allele was more common in patients with asthma than in control subjects (allele frequencies 0.19 vs 0.08, χ 2 = 12.40, p = 0.001, odds ratio = 2.62). These differences were accentuated when only patients with allergic asthma were included in the analysis (allele frequency = 0.21, χ 2 = 15.13, p = 0.001, odds ratio = 2.95). These data suggest that inherited variation in histamine metabolism might be one factor involved in the pathophysiology and pharmacogenetics of asthma - particularly in patients who suffer from atopy.

Original languageEnglish (US)
Pages (from-to)146
Number of pages1
JournalClinical Pharmacology and Therapeutics
Volume65
Issue number2
StatePublished - 1999

Fingerprint

Histamine N-Methyltransferase
Pharmacogenetics
Genetic Polymorphisms
Asthma
Gene Frequency
Histamine
Odds Ratio
Biotransformation
Blood Donors
Epithelium
Public Health
Alleles
Amino Acids
Genes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Histamine N-methyltransferase (HNMT) pharmacogenetics : Association of the C314T genetic polymorphism with allergic asthma. / Yan, L.; Galinsky, R. E.; Liggett, S. B.; Weinshilboum, Richard M.

In: Clinical Pharmacology and Therapeutics, Vol. 65, No. 2, 1999, p. 146.

Research output: Contribution to journalArticle

@article{09285cb61ef541eead76e6c1f82335ec,
title = "Histamine N-methyltransferase (HNMT) pharmacogenetics: Association of the C314T genetic polymorphism with allergic asthma",
abstract = "Asthma is an important public health problem that affects an estimated 150 million individuals worldwide. HNMT plays a dominant role in histamine biotransformation in bronchial epithelium. We have described a C314T polymorphism within the HNMT gene that results in a Thr105I1e change in encoded amino acid as well as decreased HNMT activity. We set out to determine whether this common genetic polymorphism might represent a risk factor for asthma. 63 asthmatic patients as well as 237 randomly selected blood donors were genotyped for the C314T polymorphism. The T314 variant allele was more common in patients with asthma than in control subjects (allele frequencies 0.19 vs 0.08, χ 2 = 12.40, p = 0.001, odds ratio = 2.62). These differences were accentuated when only patients with allergic asthma were included in the analysis (allele frequency = 0.21, χ 2 = 15.13, p = 0.001, odds ratio = 2.95). These data suggest that inherited variation in histamine metabolism might be one factor involved in the pathophysiology and pharmacogenetics of asthma - particularly in patients who suffer from atopy.",
author = "L. Yan and Galinsky, {R. E.} and Liggett, {S. B.} and Weinshilboum, {Richard M}",
year = "1999",
language = "English (US)",
volume = "65",
pages = "146",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Histamine N-methyltransferase (HNMT) pharmacogenetics

T2 - Association of the C314T genetic polymorphism with allergic asthma

AU - Yan, L.

AU - Galinsky, R. E.

AU - Liggett, S. B.

AU - Weinshilboum, Richard M

PY - 1999

Y1 - 1999

N2 - Asthma is an important public health problem that affects an estimated 150 million individuals worldwide. HNMT plays a dominant role in histamine biotransformation in bronchial epithelium. We have described a C314T polymorphism within the HNMT gene that results in a Thr105I1e change in encoded amino acid as well as decreased HNMT activity. We set out to determine whether this common genetic polymorphism might represent a risk factor for asthma. 63 asthmatic patients as well as 237 randomly selected blood donors were genotyped for the C314T polymorphism. The T314 variant allele was more common in patients with asthma than in control subjects (allele frequencies 0.19 vs 0.08, χ 2 = 12.40, p = 0.001, odds ratio = 2.62). These differences were accentuated when only patients with allergic asthma were included in the analysis (allele frequency = 0.21, χ 2 = 15.13, p = 0.001, odds ratio = 2.95). These data suggest that inherited variation in histamine metabolism might be one factor involved in the pathophysiology and pharmacogenetics of asthma - particularly in patients who suffer from atopy.

AB - Asthma is an important public health problem that affects an estimated 150 million individuals worldwide. HNMT plays a dominant role in histamine biotransformation in bronchial epithelium. We have described a C314T polymorphism within the HNMT gene that results in a Thr105I1e change in encoded amino acid as well as decreased HNMT activity. We set out to determine whether this common genetic polymorphism might represent a risk factor for asthma. 63 asthmatic patients as well as 237 randomly selected blood donors were genotyped for the C314T polymorphism. The T314 variant allele was more common in patients with asthma than in control subjects (allele frequencies 0.19 vs 0.08, χ 2 = 12.40, p = 0.001, odds ratio = 2.62). These differences were accentuated when only patients with allergic asthma were included in the analysis (allele frequency = 0.21, χ 2 = 15.13, p = 0.001, odds ratio = 2.95). These data suggest that inherited variation in histamine metabolism might be one factor involved in the pathophysiology and pharmacogenetics of asthma - particularly in patients who suffer from atopy.

UR - http://www.scopus.com/inward/record.url?scp=33749088555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749088555&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 146

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -